Ambitious goals and hard work – that’s what 46-year-old Xue Bing’s life revolved around. As cofounder of a rapidly growing teambuilding firm, he was realizing the high achiever’s dream. His job was to motivate and excite other people – but he lost his own spark to severe depression.
With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.
Through our sustainability strategy, we mitigate business risks, reduce negative impacts, and address societal challenges where possible. We remain committed to UN Global Compact Principles, and contribute to seven of the 17 UN Sustainable Development Goals.
The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.
